Intensity-Modulated Radiation Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Photon IMRT falls short in glioblastoma study
A dose-intensification protocol used with intensity-modulated radiation therapy...Read more on AuntMinnie.comRelated Reading:
PET with Axumin boosts prostate cancer outcomes
Single-session SBRT speeds treatment of lung metastases
SNMMI 2020: PET tracer could image, treat glioblastoma
NRG Oncology receives $95M in NCI funding
FLT-PET points toward survival for glioblastoma patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 27, 2020 Category: Radiology Source Type: news
Photon IMRT treatment group displays no significant survival difference between arms
(NRG Oncology) A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical trial NRG-BN001 indicates that there is no statistically significant overall survival (OS) or toxicity differences between dose-intensification radiation therapy (DI-RT) using intensity-modulated radiation therapy (IMRT) and standard-dose radiation therapy (SD-RT) with temozolomide treatments for patients with newly diagnosed glioblastoma (GBM). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2020 Category: International Medicine & Public Health Source Type: news
Digital FDG-PET offers insights to hearing loss
The use of digital PET to measure FDG uptake in the area of the brain devoted...Read more on AuntMinnie.comRelated Reading:
Flat-panel CT helps refine pitch for cochlear implant users
ARRS: CBCT outperforms MDCT for hearing loss
IMRT reduces risk of hearing loss in pediatric medulloblastoma patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 30, 2020 Category: Radiology Source Type: news
10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer
MONDAY, March 23, 2020 -- For men with intermediate- and high-risk prostate adenocarcinoma, 10-year outcomes are similar with conventionally fractionated intensity-modulated radiation therapy (C-IMRT) or moderate hypofractionated IMRT (H-IMRT),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 23, 2020 Category: Pharmaceuticals Source Type: news
Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment
A web-based tool can help predict functional outcomes for five years after treatment of localized prostate cancer with radical prostatectomy (RP), intensity-modulated radiation therapy (RT), or active surveillance, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 18, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Study to Clarify Radiation Benefits in Mesothelioma Patients
An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery for patients with pleural mesothelioma.
The trial will be the first multicenter, randomized study measuring both safety and potential survival benefits of intensity-modulated radiation therapy (IMRT) and pencil-beam scanning with pleurectomy and decortication surgery and chemotherapy.
The trial is sponsored by NRG Oncology and will involve several mesothelioma specialty centers across the country. The goal is to enroll a combined 150 patients.
...
Source: Asbestos and Mesothelioma News - March 3, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news
Intensity-Modulated Radiation Charges for Prostate Cancer Vary
TUESDAY, Jan. 21, 2020 -- There is considerable variation in listed charges for simple intensity-modulated radiation therapy used in prostate cancer treatment, with a weak positive association for price and geographic practice cost index, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2020 Category: Pharmaceuticals Source Type: news
Varian Uses AI to Usher in New Era of Cancer Therapy at ASTRO
Four years ago, Varian’s Applied Research Team, a group separate from its research and development unit, began looking at how to incorporate artificial intelligence into cancer therapy. The team’s hard work has resulted in the development of Ethos, an AI-driven holistic solution designed to increase the efficiency of radiotherapy.
MD+DI spoke with Chris Toth, president of Varian Oncology Systems ahead of Ethos’ launch at the American Society for Radiation Oncology [ASTRO] annual meeting in Chicago held this week. Ethos is an Adaptive Intelligence solution.
T...
Source: MDDI - September 13, 2019 Category: Medical Devices Authors: Omar Ford Tags: Imaging Source Type: news
Herlev University Hospital Treats First Patient in Denmark on Varian Halcyon System
Palo Alto, Calif. and Herlev, Denmark, June 10, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was a 42-year-old female undergoing treatment for anal cancer. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient...This story is related to the following:Medical Equipment Machinery (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - June 11, 2019 Category: Medical Devices Source Type: news
Ofuna Chuo Hospital Delivers First Varian Halcyon System Treatments in Japan
PALO ALTO, Calif., April 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan is the first clinic in the country to begin treating cancer patients using the Halcyon™ radiotherapy system. The Halcyon system simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - April 30, 2019 Category: Medical Devices Source Type: news
Mesothelioma Treatment Combines Proton and Photodynamic Therapy
Intraoperative photodynamic therapy combined with novel proton radiation improved survival time significantly for recent patients with advanced-stage pleural mesothelioma.
The study — the first to measure the impact of this combination — involved 10 consecutive patients treated at the University of Pennsylvania’s Abramson Cancer Center.
The treatment regimen resulted in a 90 percent, two-year disease control rate and an impressive 30.3-month median overall survival from the time of diagnosis.
All 10 patients were diagnosed before treatment began with stage 3 or stage 4 disease, which typically results in a 10 to 14-m...
Source: Asbestos and Mesothelioma News - March 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
OIG: Medicare contractors overpaid for radiation therapies
Medicare contractors may have significantly overpaid for intensity-modulated radiation therapy services, according to a new report from the U.S. Dept. of Health and Human Services’ Office of the Inspector General.
In its report, the OIG said that it reviewed claims paid to hospitals from National Government Services, Inc., that contained specific IMRT services at risk for noncompliance with Medicare requirements. The office identified 25,9000 claims paid by NGS that contained “potentially unallowable IMRT services totaling $80.1 million.”
The federal watchdog estimates that Centers for Medicare and Medicaid S...
Source: Mass Device - December 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Dept. of Health & Human Services (HHS) Source Type: news
CT lung screening can catch recurring head, neck cancer
CT lung screening may have added value in cancer detection beyond the chest,...Read more on AuntMinnie.comRelated Reading:
PET/CT remains best option for head, neck cancer
PET/CT after therapy avoids surgery for head, neck cancer
Lung plus head/neck cancer screening delivers high yields
PET/CT details hint at survival of head and neck cancer patients
IMRT confers survival benefit for head and neck cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2018 Category: Radiology Source Type: news
The Verdict on IMRT Plus Doxorubicin in Unresectable Thyroid Cancer
A study inThyroid evaluated the safety and efficacy of concurrent intensity-modulated radiation therapy and doxorubicin in thyroid cancer. (Source: CancerNetwork)
Source: CancerNetwork - November 13, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news
Industry funding concentrated in radiation oncology
The vast majority of industry payments to radiation oncology researchers are...Read more on AuntMinnie.comRelated Reading:
HHS audit finds hospitals overbill for IMRT planning
Neurorads receive highest industry payments
Self-referral 'sunshine' bill introduced in House (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2018 Category: Radiology Source Type: news
